Related Experiment Video
Updated: Jun 15, 2026

Optimization of the Longa Middle Cerebral Artery Occlusion Method for Complete Reperfusion
Published on: November 22, 2024
Submaximal Angioplasty for Severe Intracranial Atherosclerotic Stenosis: Benefit of Revascularization at Last
Umberto Pensato1,2, Andrew M Demchuk3, Geoffrey A Donnan4
1Department of Neurology, IRCCS Humanitas Research Hospital, Milan, Italy (U.P.).
Insights
Balloon angioplasty for symptomatic intracranial artery stenosis (BASIS) trial shows endovascular treatment benefits. Submaximal balloon angioplasty may offer a balance between safety and efficacy for stroke prevention.
Area of Science:
- Neurology
- Vascular Surgery
- Interventional Cardiology
Background:
- Intracranial atherosclerotic stenosis is a major cause of stroke, with high recurrence risk.
- Previous trials of angioplasty and stenting for intracranial stenosis yielded negative or neutral results.
- Coronary artery disease interventions inspired exploration of similar approaches for intracranial disease.
Purpose of the Study:
- To evaluate the efficacy and safety of endovascular treatment for symptomatic intracranial atherosclerotic stenosis.
- To determine if submaximal balloon angioplasty improves outcomes compared to previous approaches.
Main Methods:
- The BASIS trial was a randomized trial investigating balloon angioplasty for symptomatic intracranial artery stenosis.
- Focused on submaximal balloon angioplasty to balance early complications and long-term efficacy.
Main Results:
- The BASIS trial demonstrated the benefits of endovascular treatment in this patient population.
- Submaximal balloon angioplasty emerged as a potentially optimal technique.
Conclusions:
- Endovascular treatment, specifically submaximal balloon angioplasty, shows promise for secondary stroke prevention in intracranial atherosclerotic stenosis.
- Further research is needed to address remaining uncertainties before widespread clinical adoption.
Abstract:
Intracranial atherosclerotic stenosis is a leading cause of stroke with a significant risk of recurrent ischemic events despite aggressive medical management. The longstanding benefits of percutaneous angioplasty and stenting in coronary artery disease, where atherosclerosis is the overarching cause in nearly all cases, provided a compelling rationale for exploring similar interventions in intracranial atherosclerotic stenosis. However, 3 percutaneous angioplasty and stenting randomized trials showed negative or neutral results. The recent BASIS trial (Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis) was the first randomized trial in intracranial atherosclerotic stenosis to demonstrate the benefits of endovascular treatment, suggesting that submaximal balloon angioplasty might be in the sweet spot between mitigating early complications and securing long-term efficacy. These findings represent a significant advancement in the field, reinvigorating the goal of effective revascularization as a viable secondary prevention approach for intracranial atherosclerotic stenosis. However, several uncertainties still need to be addressed before the widespread implementation of angioplasty in clinical practice.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Aneurysm III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care

